CAR-T Meeting 2024 | CAR-T in myeloma: will it provide a cure?
Borja Puertas-Martinez
• 16 Feb 2024
In this video, Borja Puertas-Martínez, MD, University Hospital of Salamanca, Salamanca, Spain, discusses the future direction of CAR T-cell therapy in the field of multiple myeloma (MM) and comments on whether he believes this therapeutic approach will present a curative option for patients. Due to the heterogeneity of this malignancy, Dr Puertas-Martínez is skeptical that CAR-T therapy alone will provide a cure. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
